Tumor necrosis factor-α inhibitor-induced psoriasis in juvenile idiopathic arthritis patients.
Daniel GrothMaria PerezJames R TreatLeslie A Castelo-SoccioSimona NativPamela F WeissSivia LapidusMarissa J PermanPublished in: Pediatric dermatology (2019)
Our findings demonstrate the prevalence of TNFi-induced psoriasis in JIA at two centers. Though larger studies are needed, our data suggest discontinuation of TNFi or biologic class switching should be considered as treatment strategies in select patients.
Keyphrases
- juvenile idiopathic arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis
- prognostic factors
- peritoneal dialysis
- high glucose
- patient reported outcomes
- deep learning
- electronic health record
- systemic lupus erythematosus
- artificial intelligence
- atopic dermatitis